CEL-SCI Corporation – Asian Scientist Magazine

subscribe

cel sci corporation

Pharma

CEL-SCI’s Phase III Trial Enrols Patients From Sri Lanka

CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.

Pharma

CEL-SCI Starts Ph III Trials For Head And Neck Cancer In Taiwan

CEL-SCI has initiated Phase III clinical trials in Taiwan for its head and neck cancer immunotherapy drug.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.